|
The Purdue/Mundipharma/Napp
independent associated companies are
privately owned companies and joint ventures covering
the world's pharmaceutical markets. The companies have
particular expertise in drug delivery systems and these
are applied to our range of analgesics, respiratory
treatments, and cardiovascular drugs.
The companies also have a growing presence in the
oncology market, and products in the areas of laxatives
and antiseptics.
|
The companies employ around
4,000 employees
and have ex-company sales of approximately $1.75
billion of which a
significant proportion are from licensed-in products. We
have research and production centres in the US,
UK, Canada and Germany and, through our joint
ventures, in India, China, Latin
America and Cyprus.
|
|
 |
Our
philosophy is a wholehearted commitment to the quality
of corporate work, high standards of endeavour and
cooperation.
|
|
|
|
An entrepreneurial approach
has resulted in international
coverage of established and evolving pharmaceutical
markets. A strength in sales and marketing
has resulted in proven success in third party collaborations
and licensing. This strength is supported by
the
capability to provide full development, medical,
registration and manufacturing operations.
|
| Modern
and efficient technology is employed in a quality
controlled environment |
|
The Independent Associated Companies
The companies
include pharmaceutical companies in North America,
Europe and Asia, with joint ventures in India, China, Argentina, Brazil, Mexico and Cyprus.
The Purdue Pharma Company, founded in 1892 in New York City, was
acquired by Dr Mortimer D Sackler and Dr Raymond
R Sackler in 1952. Today Purdue has four major
sites: Stamford, Connecticut (headquarters);
Cranbury,
New Jersey(research and development); Totowa, New
Jersey (manufacturing); Wilson, North Carolina,
with a staff of over 1000.
|
|
 |
US Headquarters of Purdue |
|
|
|
Purdue Pharma of Canada. The company
was established in 1956, and in the summer of
1991, a new factory, research facility and administrative
corporate headquarters were opened in Pickering
near Toronto
Mundipharma AG, Basel, Switzerland was
the first Mundipharma company established in 1957
and functions as an international licensing and
trading company. It has a worldwide
licensing and distribution network with sales
of licensed products in over 100 countries. These
include successful third party collaborations
and licensing in the Middle East,
Asia and Africa.
|
Headquarters of Purdue Pharma, Canada |
|
Mundipharma Medical Company (MMCO),
also based in Basel, markets our products in Switzerland.
Napp Pharmaceutical Group, Cambridge,
UK has sales and marketing, research, manufacturing
and administrative facilities - employs over
800
people.
|
|
 |
Headquarters of Napp,
Cambridge, UK (click to enlarge) |
|
Mundipharma GmbH is based in Limburg,
near Frankfurt, Germany, and employs over
600
people. It offers
research, manufacturing and sales & marketing
capabilities.
Mundipharma GesmbH, Vienna, Austria -
covers the Austrian prescription and consumer
markets.
Rafa, Jerusalem, Israel.
Norpharma A/S, Copenhagen, Denmark.
Mundipharma Oy, Finland.
Mundipharma AB, Sweden.
Mundipharma AS, Norway.
Mundipharma Medical Company, Republic
of Ireland.
Mundipharma SARL, France
Mundipharma Pharmaceuticals BV, BeNeLux
Mundipharma SL, Spain
Mundipharma Srl, Italy
Mundipharma Pharmaceuticals Limited, Cyprus
Modi-Mundipharma Limited, New Delhi, India
is a joint venture company - it manufactures and
markets the Group's products and employs over
1000 people.
Beijing Mundipharma Pharmaceutical Company
Limited, China is a joint venture between
the Mundipharma Group and Beijing Pharmaceutical
Works.
Mundipharma YH, Korea
Mundipharma Japan, Japan
Mundipharma Pty Ltd, Australia
|
|
